Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor

Journal of Neurosurgery

Volumn 89, Issue 2, 1998, Pages 279-288

  Wolf, Erich W ^a   Banerjee, Amit ^a   Soble Smith, Jill ^a   Dohan Jr , F Curtis ^a   White, Richard P ^a   Robertson, James T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cerebrospinal fluid; DETA NO; Dog; Double hemorrhage model; Hemoglobin; Nitric oxide; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

1 [N (2 AMINOETHYL) N (2 AMMONIOETHYL)AMINIO]DIAZEN 1 IUM 1,2 DIOLATE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN CIRCULATION; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; INTRATHECAL DRUG ADMINISTRATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

EID: 0031845716     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.89.2.0279     Document Type: Article

References (72)

1. Adams JE, Prawirohardjo S: Fate of red blood cells injected into cerebrospinal fluid pathways. Neurology 9:561-564, 1959
2. Afshar JKB, Pluta RM, Boock RJ, et al: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118-122, 1995
3. Allen GS, Ahn HS, Preziosi TJ, et al: Cerebral arterial spasm -a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619-624, 1983
4. Barr JD, Mathis JM, Horton JA: Transient severe brainstem depression during intraarterial papaverine infusion for cerebral vasospasm. AJNR 15:719-723, 1994
5. Bradford FK, Johnson PC: Passage of intact iron-labeled erythrocytes from subarachnoid space to systemic circulation in dogs. Neurology 11:332-336, 1961
6. Cantilena LR, Smith RP, Frasur S, et al: Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy. J Lab Clin Med 20: 902-907, 1992
7. Clouston JE, Numaguchi Y, Zoarski GH, et al: Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR 16:27-38, 1995
8. Clyde BL, Firlik AD, Kaufmann AM, et al: Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report. J Neurosurg 84:690-695, 1996
9. Crow EL, Davis FA, Maxfield MW: Statistics Manual. New York: Dover Press, 1960, pp 62-64
10. Dawson TM, Dawson VL, Snyder SH: A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 32:297-311, 1992
11. Dawson VL, Dawson TM, London ED, et al: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6371, 1991
12. Drabkin DL, Austin JH: Spectrophotometric studies. II. Preparations from washed blood cells: nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 112:51-65, 1935
13. Egemen N, Türker RK, Sanlidilek U, et al: The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res 15:310-315, 1993
14. Faraci FM: Endothelium-derived vasoactive factors and regulation of the cerebral circulation. Neurosurgery 33:648-659, 1993
15. Faraci FM: Role of nitric oxide in regulation of basilar artery tone in vivo. Am J Physiol 259:H1216-H1221, 1990
16. Faraci FM, Brian JE Jr: Nitric oxide and the cerebral circulation. Stroke 25:692-703, 1994
17. Firlik AD, Kaufmann AM, Jungreis CA, et al: Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 86:830-839, 1997
18. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980
19. Frazee JG, Giannotta SL, Stern WE: Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate. J Neurosurg 55:865-868, 1981
20. Furchgott RF: Studies on relaxation of rabbit aorta by sodium nitrate, in Vanhoutte PM (ed): Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium. New York: Raven Press, 1988, pp 401-414
21. Gioia AE, White RP, Bakhtian B, et al: Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg 62:721-728, 1985
22. Goadsby PJ, Kaube H, Hoskin KL: Nitric oxide synthesis couples cerebral blood flow and metabolism. Brain Res 595: 167-170, 1992
23. Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623, 1992
24. Heros RC, Zervas NT, Lavyne MH, et al: Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy. Surg Neurol 6:227-229, 1976
25. Heros RC, Zervas NT, Varsos V: Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol 14:599-608, 1983
26. Hilton DL Jr, Einhaus SL, Meric AL III, et al: Early assessment of neurologic deficits in the fluid percussion model of brain injury. J Neurotrauma 10:121-133, 1993
27. Hino A, Tokuyama Y, Weir B, et al: Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 39:562-568, 1996
28. Hrabie JA, Klose JR, Wink DA, et al: New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 58: 1472-1476, 1993
29. Inoue T, Shimizu H, Kaminuma T, et al: Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys. Neurosurgery 39:984-990, 1996
30. Kajita Y, Suzuki Y, Oyama H, et al: Effects of LP-805, a releaser of endothelium-derived nitric oxide, on ion channels in cultured endothelial cells, in Findlay JM (ed): Cerebral Vasospasm. Amsterdam: Elsevier, 1993, pp 239-242
31. Kanner J, Harel S, Granit R: Nitric oxide as an antioxidant. Arch Biochem Biophys 289:130-136, 1991
32. Kassell NF, Peerless SJ, Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337-343, 1982
33. Kassell NF, Torner JC, Haley EC, et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990
34. Kennady JC: Investigations of the early fate and removal of subarachnoid blood. Pacific Med Surg 75:163-168, 1967
35. Khajavi K, Ayzman I, Shearer D, et al: Prevention of chronic cerebral vasospasm in dogs with milrinone. Neurosurgery 40: 354-362, 1997
36. Kodama N, Sasaki T, Yamanobe K, et al: Prevention of vasospasm: cisternal irrigation therapy with urokinase and ascorbic acid, in Wilkins RH (ed): Cerebral Vasospasm. New York: Raven Press, 1988, pp 415-418
37. Kontos H: Nitric oxide and nitrosothiols in cerebrovascular and neuronal regulation. Stroke 24 (Suppl 12): I155-I158, 1993
38. Kosnik EJ, Hunt WE: Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 45:148-154, 1976
39. Kowaluk EA, Seth P, Fung H: Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharm Exp Ther 262:916-922, 1992
40. Levy ML, Giannotta SL: Induced hypertension and hypervolemia for treatment of cerebral vasospasm. Neurosurg Clin North Am 1:357-365, 1990
41. Linskey ME, Horton JA, Rao GR, et al: Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. Case report. J Neurosurg 74:985-990, 1991
42. Lipton SA, Chol YB, Pan ZH, et al: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632, 1993
43. Lipton SA, Singel DJ, Stamler JS: Redox-activated states of nitric oxide determine neuronal protection versus neuronal injury, in Takagi H, Toda N, Hawkins RD (eds): Nitric Oxide. Roles in Neuronal Communication and Neurotoxicity. Taniguchi Symposia on Brain Sciences, Vol 17. Tokyo: Japan Scientific Societies Press, 1994, pp 183-189
44. Liszczak TM, Varsos VG, Black PM, et al: Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 58:18-26, 1983
45. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991
46. Milter JA, Cross DT, Moran CJ, et al: Severe thrombocytopenia following intraarterial papaverine administration for treatment of vasospasm. J Neurosurg 83:435-437, 1995
47. Petruk KC, West M, Mohr G, et al: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505-517, 1988
48. Pistoia F, Horton JA, Sekhar L, et al: Imaging of blood flow changes following angioplasty for treatment of vasospasm. AJNR 12:446-448, 1991
49. Pluta RM, Oldfield EH, Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746-751, 1997
50. Pluta RM, Thompson BG, Dawson TM, et al. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648-654, 1996
51. Press WH, Flannery BP, Teukolsky SA, et al: Numerical Recipes in Pascal. New York: Cambridge University Press, 1992
52. Rosenblum WI, Nishimura H, Nelson GH: Endothelium-dependent L-Arg-and L-NMMA-sensitive mechanisms regulate tone of brain microvessels. Am J Physiol 259:H1396-H1401, 1990
53. Rubanyi GM: Endothelium-derived relaxing and contracting factors. J Cell Biochem 46:27-36, 1991
54. Schievink WI: Intracranial aneurysms. N Engl J Med 336: 28-40, 1997
55. Simmonds WJ: The absorption of blood from the cerebrospinal fluid in animals. Austral J Exp Biol 30:261-270, 1952
56. Smith RP, Louis CA, Kruszyna R, et al: Acute neurotoxicity of sodium azide and nitric oxide. Fundam Appl Toxicol 17: 120-127, 1991
57. Solomon RA, Fink ME, Lennihan L: Prophylactic volume expansion therapy for the prevention of delayed cerebral ischemia after early aneurysm surgery. Results of a preliminary trial. Arch Neurol 45:325-332, 1988
58. Sonobe M, Suzuki J: Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir 44:97-106, 1978
59. Sprong W: The disappearance of blood from the cerebrospinal fluid in traumatic subarachnoid haemorrhage. The ineffectiveness of repeated lumbar punctures. Surg Gynecol Obstet 58: 705-710, 1934
60. Suzuki Y, Osuka K, Noda A, et al: Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage. Neurosurgery 41:807-812, 1997
61. Thompson BG, Pluta RM, Girton M, et al: Nitric oxide (NO) mediates chemoregulation of CBF in primates. Stroke 23:154, 1992 (Abstract)
62. Tsukahara T, Yoshimura S, Kazekawa K, et al: Intra-arterial papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Auton, Nerv Syst 49 (Suppl): S163-S166, 1994
63. Vardiman AB, Kopitnik TA, Purdy PD, et al: Treatment of traumatic arterial vasospasm with intraarterial papaverine infusion. AJNR 16:319-321, 1995
64. Wennmalm Å, Benthin G, Edlund A, et al: Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73:1121-1127, 1993
65. Wennmalm A, Benthin G, Petersson AS: Dependence of the 65' metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 106:507-508, 1992
66. White RP: Responses of isolated cerebral arteries to vasoactive agents Neurosurg Clin North Am 1:401-415, 1990
67. White RP, Hagen AA, Robertson JT: Effect of nonsteroid anti-inflammatory drugs on subarachnoid hemorrhage in dogs. J Neurosurg 51:164-171, 1979
68. White RP, Robertson JT: Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in chronic model of cerebral vasospasm. Neurosurgery 12:40-46, 1983
69. Wilkins RH: Attempts at prevention or treatment of intracranial arterial spasm: an update. Neurosurgery 18:808-825, 1986
70. Wink DA, Cook JA, Pacelli R, et al: The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. Arch Biochem Biophys 331:241-248, 1996
71. Wink DA, Hanbauer I, Krishna MC, et al: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Nat Acad Sci USA 90:9813-9817, 1993
72. Zubkov YN, Nikiforov BM, Shustin VA: Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir 70:65-79, 1984